
bit.bio
bit.bio is an award-winning human synthetic biology company whose mission is to code cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox™ precision cell programing technology, bit.bio can deterministically program human induced pluripotent stem cells (iPSCs) into a chosen cell identity with unprecedented biological consistency at an industrial scale and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.
Latest bit.bio Content

Developing Next-Generation In Vitro Phenotypic Assays for Huntington’s Disease

Alzheimer's Disease Pathogenesis: Emerging Role of Microglia

ioMicroglia™ – Consistent iPSC-Derived Microglia, Ready in 10 Days!

bit.bio Adds Two New Human Cell Products To Accelerate Research and Drug Discovery for Neurodegenerative Disease

Combining Coding and Biology To Engineer Human Cells
